Kaya Holdings (KAYS) Other Non-Current Liabilities (2014 - 2025)
Kaya Holdings (KAYS) recorded quarterly Other Non-Current Liabilities of $503789.0 in Q3 2025, up 0.76% quarter-over-quarter from $500000.0 in Q2 2025, and up 0.76% on a YoY basis from $500000.0 in Q3 2024.
Kaya Holdings (KAYS) Other Non-Current Liabilities (2014 - 2025) Analysis & Trends
Kaya Holdings' Other Non-Current Liabilities history runs 12 years deep, the most recent figure standing at $503789.0 for Q3 2025.
- In Q3 2025, Other Non-Current Liabilities rose 0.76% year-over-year to $503789.0; the TTM figure through Sep 2025 stood at $503789.0 (up 0.76% YoY), while the FY2024 annual figure was $500000.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities was $503789.0 for Q3 2025 at Kaya Holdings, up from $500000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $17.3 million in Q1 2021 to a low of $500000.0 in Q4 2023.
- Historically, Other Non-Current Liabilities has averaged $4.5 million across 5 years, with a median of $3.5 million in 2023.
- Biggest YoY gain for Other Non-Current Liabilities was 228.17% in 2023; the steepest drop was 91.94% in 2023.
- A 5-year view of Other Non-Current Liabilities shows it stood at $6.2 million in 2021, then changed by 0.0% to $6.2 million in 2022, then tumbled by 91.94% to $500000.0 in 2023, then changed by 0.0% to $500000.0 in 2024, then increased by 0.76% to $503789.0 in 2025.
- The last three Other Non-Current Liabilities figures came in at $503789.0 (Q3 2025), $500000.0 (Q2 2025), and $500000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 503,789.00 |
| Jun 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 621,921.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 3.52 Mn |
| Jun 30, 2023 | 6.20 Mn |
| Mar 31, 2023 | 5.52 Mn |
| Dec 31, 2022 | 6.20 Mn |
| Sep 30, 2022 | 9.00 Mn |
| Jun 30, 2022 | 1.89 Mn |
| Mar 31, 2022 | 5.53 Mn |
| Dec 31, 2021 | 6.20 Mn |
| Sep 30, 2021 | 8.10 Mn |
| Jun 30, 2021 | 12.66 Mn |
| Mar 31, 2021 | 17.33 Mn |
| Dec 31, 2020 | 17.33 Mn |